Password

Search

Single agent Taxol for relapsed small cell lung cancer – pro

Small cell lung cancer that progresses after first line chemotherapy has a poor prognosis. A variety of treatments are available, among them single agent Taxol.The literature contains studies in various schedules, including weekly and dose-dense, as well as various combination therapies. Single agent Taxol is also listed for sequential use by NCCN. However, combination regimesn with Taxol have some phase II data, but are not supported by guidelines, such as NCCN and others.